Vidutolimod (CMP-001) isa CpG-A oligodeoxynucleotide. Vidutolimod is a Toll-like receptor 9 ( TLR9 ) agonist, which activates plasmacytoid dendritic cells (pDCs) and triggers interferon alpha (IFNα) release, leading to a cascade of anti-tumor immune effects.